参考文献/References:
[1] 王艺红.哮喘干预始于孕前[J].江苏卫生保健,2015,16(19):43.
[2] Ameis D,Khoshgoo N,Iwasiow BM,et al. MicroRNAs in lung development and disease[J].Paediatric Respiratory Reviews,2017,22:38-43.
[3] Shi ZG,Sun Y,Wang KS,et al. Effects of miR-26a/miR-146a/miR-31 on airway inflammation of asthma mice and asthma children[J].European Review for Medical and Pharmacological Sciences,2019,23(12):5432.
[4] Hannafon BN,Cai A,Calloway CL,et al. miR-23b and miR-27b are oncogenic microRNAs in breast cancer:Evidence from a CRISPR/Cas9 deletion study[J].BMC Cancer,2019,19(1):1-12.
[5] 全细云,李 明,陈栋良,等.胃癌组织中microRNA-214和MGAT5表达及预后的相关性分析[J].陕西医学杂志,2019,48(1):117-120.
[6] 韩 乐,陈文娟,雷光焰,等.microRNA-21、microRNA-25在肺癌组织中的表达及意义[J].陕西医学杂志,2019,48(12):1596-1600.
[7] 赵 垚.miR-506和miR-542-3p在恶变的支气管上皮细胞中的功能[D].广州:广州医学院,2011.
[8] 李芙蓉,王捷军.儿童支气管哮喘控制不良因素中鼻窦炎患病率观察[J].中国实用内科杂志,2014,25(5):106-108.
[9] 林 惠,颜 芬.微小RNA-195-5p与脑源性神经营养因子在哮喘急性发作期患儿血清中表达相关性研究[J].陕西医学杂志,2020,49(7):862-865.
[10] 邢西迁,杨 姣,白 敏,等.哮喘miRNA-mRNA调节网络的构建与小分子药物的预测[J].中国临床药理学杂志,2021,37(4):454-457.
[11] Liu B,Li J,Zheng M,et al. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2[J].Life Sciences,2017,188:87-95.
[12] Tao J,Liu Z,Wang Y,et al. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C[J].Biomedicine & Pharmacotherapy,2017,93:420-428.
[13] Li J,Shao W,Feng H.MiR-542-3p,a microRNA targeting CDK14,suppresses cell proliferation,invasiveness,and tumorigenesis of epithelial ovarian cancer[J].Biomedicine & Pharmacotherapy,2019,110:850-856.
[14] 赵 垚,刘焕英,李远奇,等. miR-542-3p在反式-7,8-二羟-9,10-环氧苯并芘诱导致癌中的作用[J].中华预防医学杂志,2011,45(5):416-421.
[15] 王 跃,郑志超,谷小虎,等.miRNA-542-3p对胃腺癌细胞侵袭转移能力的影响[J].解剖科学进展,2018,24(1):72-75.
[16] 李沛隆,连 杰,林 娜,等.白细胞介素-33与儿童支气管哮喘的相关性研究进展[J].新乡医学院学报,2021,38(4):374-377.
[17] 李 鑫 刘圆圆,张才擎.白介素-33在支气管哮喘发病机制中的作用[J].中华临床医师杂志:电子版,2019,13(5):389-392.
[18] Rankin AL,Mumm JB,Murphy E,et al. IL-33 induces IL-13-Dependent cutaneous fibrosis[J].Journal of Immunology,2010,184(3):1526-1535.
[19] Tajima S,Oshikawa K,Tominaga S,et al. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis[J].Chest,2003,124(4):1206-1214.